New Addiction Medicine Section
Don’t miss a single podcast of CMDA Matters. You can subscribe through iTunes or GooglePlay, download our free CMDA app and or listen on our website at www.cmda.org/cmdamatters. This weekly podcast hosted by Dr. Mike Chupp features one interview with brief news and announcements that matter to you.
Dr. Warren Yamashita and Dr. Kurt Bravata join Dr. Mike Chupp on this week’s CMDA Matters podcast to discuss CMDA’s new Addiction Medicine Section.
Meet Our Guest
Warren Yamashita, MD, MPH, is a family medicine and addiction medicine physician who recently graduated from the Stanford Addiction Fellowship. He is currently at KCS Federally Qualified Health Center in Anaheim, California providing family medicine, addiction medicine, integrated behavioral health and homeless services. He is also a Stanford Addiction Medicine Fellowship Adjunct Instructor where he leads their Diversity, Equity and Inclusion didactics with a biblical frame. He gave a CMDA 2021 National Convention workshop on the stigmatization of addiction and race in America. He also serves on the CMDA Racism, Reconciliation, Equality and Diversity (R2ED) Committee to address the ethnic and racial disparities with a biblical worldview.
Kurt Bravata, MD, grew up in a Christian home where his parents were involved in ministry outreaches to the poor, outcast and downtrodden. From a young age he was impressed by the joy and fulfillment of seeing lives restored and hope given to the hopeless. He determined early on that he wanted to follow Christ and make a real and lasting difference in people’s lives. Although Dr. Bravata did initially set out to become an addictionologist, he soon felt called by God to share his grace by helping to lead people out of lives of deeply rooted hurt, dysfunction and addiction. As a family physician, Dr. Bravata simply responded to the need for effective, evidence-based treatment of substance use disorders in his rural patient population. This growing passion led Dr. Bravata to seek education in addiction medicine, become DATA 2000 waivered to prescribe buprenorphine, and eventually obtain Addiction Medicine Board Certification through the practice pathway provided by the American Board of Preventive Medicine (ABPM). Along the way, Dr. Bravata has been involved in local and national Family and Addiction Medicine leadership, education, and publication.
RESOURCES
